Delivery Order SPE2DX22D0010-SPE2D825FGR02
Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $62K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,376.94 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, for the supply of Vyvanse 60 mg capsules. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of September 17, 2025, and will be performed at the company's Conshohocken facility. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Vyvanse 60 mg capsules (100 count) with a ceiling value of $1,190.33 and an ultimate completion date of April 25, 2025. The award represents a non-competitive, non-set-aside procurement and is classified as a child contract under a larger vehicle. The place of performance is located at AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,377.46 by the Defense Logistics Agency on September 22, 2025, for the supply of Vyvanse 50 mg capsules (100 count). The award, which is not set-aside and employs firm fixed price terms, represents a single delivery order under a larger contract vehicle. This order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Vyvanse 60 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $1,946.30. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by April 25, 2025. This delivery order represents a continuation of AmerisourceBergen's role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for Vyvanse 20 mg capsules (100 count) with a ceiling value of $9,282.09. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 5, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $6,108.12 delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Vyvanse 10 mg capsules (100-count units). This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,904.90 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, for the supply of Vyvanse 30 milligram capsules (100 count). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and was competitively awarded without set-aside designation. This award falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 25, 2025, to supply 100 capsules of Vyvanse 70 mg under a firm fixed-price contract valued at $5,805.00. The contract was competitively awarded with no set-aside designation and has an ultimate completion date of September 26, 2025. The place of performance is listed as Conshohocken, Pennsylvania, and the funding agency is the Defense Logistics...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Vyvanse Capsules 30mg valued at $28,322.59 on October 8, 2025, with an ultimate completion date of October 9, 2025. The contract is non-competitive, firm fixed-price delivery order issued under the Defense Logistics Agency's Medical Supply Chain function. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 17, 2025, for 100 capsules of Vyvanse 30 mg with a ceiling value of $5,090.67. This competitively awarded, non-set-aside order is funded by the Defense Logistics Agency (DLA) and will be performed at the contractor's Conshohocken facility. The award represents a single delivery order under a larger Indefinite Delivery Contract vehicle. This...